184 related articles for article (PubMed ID: 1364845)
1. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat.
Barrand MA; Callingham BA; Dobbin P; Hider RC
Br J Pharmacol; 1991 Mar; 102(3):723-9. PubMed ID: 1364845
[TBL] [Abstract][Full Text] [Related]
2. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.
Barrand MA; Callingham BA
Br J Pharmacol; 1991 Feb; 102(2):408-14. PubMed ID: 2015422
[TBL] [Abstract][Full Text] [Related]
3. The importance of reductive mechanisms for intestinal uptake of iron from ferric maltol and ferric nitrilotriacetic acid (NTA).
Barrand MA; Hider RC; Callingham BA
J Pharm Pharmacol; 1990 Apr; 42(4):279-82. PubMed ID: 1974298
[TBL] [Abstract][Full Text] [Related]
4. Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine.
Barrand MA; Callingham BA; Hider RC
J Pharm Pharmacol; 1987 Mar; 39(3):203-11. PubMed ID: 2883285
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of iron(III) uptake by isolated fragments of rat small intestine in the presence of the hydroxypyrones, maltol and ethyl maltol.
Levey JA; Barrand MA; Callingham BA; Hider RC
Biochem Pharmacol; 1988 May; 37(10):2051-7. PubMed ID: 3377810
[TBL] [Abstract][Full Text] [Related]
6. Absorption of low and therapeutic doses of ferric maltol, a novel ferric iron compound, in iron deficient subjects using a single dose iron absorption test.
Kelsey SM; Hider RC; Bloor JR; Blake DR; Gutteridge CN; Newland AC
J Clin Pharm Ther; 1991 Apr; 16(2):117-22. PubMed ID: 1856249
[TBL] [Abstract][Full Text] [Related]
7. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
[TBL] [Abstract][Full Text] [Related]
8. Intestinal absorption of cationic and anionic ferric colloids and complexes: biochemical, histochemical and morphological observations in rats.
Akita M; Seno S; Awai M
Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):1-13. PubMed ID: 2330802
[TBL] [Abstract][Full Text] [Related]
9. Absorption of ferric maltol, a novel ferric iron compound, in iron-deficient subjects.
Kelsey SM; Blake DR; Hider RC; Gutteridge CN; Newland AC
Clin Lab Haematol; 1989; 11(3):287-8. PubMed ID: 2591161
[No Abstract] [Full Text] [Related]
10. Lipid peroxidation effects of a novel iron compound, ferric maltol. A comparison with ferrous sulphate.
Singh RK; Barrand MA
J Pharm Pharmacol; 1990 Apr; 42(4):276-9. PubMed ID: 1974297
[TBL] [Abstract][Full Text] [Related]
11. Interactions between tissue uptake of lead and iron in normal and iron-deficient rats during development.
Crowe A; Morgan EH
Biol Trace Elem Res; 1996 Jun; 52(3):249-61. PubMed ID: 8811282
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
Heinrich HC
Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
[TBL] [Abstract][Full Text] [Related]
13. Assessment of iron absorption from ferric trimaltol.
Reffitt DM; Burden TJ; Seed PT; Wood J; Thompson RP; Powell JJ
Ann Clin Biochem; 2000 Jul; 37 ( Pt 4)():457-66. PubMed ID: 10902861
[TBL] [Abstract][Full Text] [Related]
14. Absorption of iron from ferric hydroxypyranone complexes.
Maxton DG; Thompson RP; Hider RC
Br J Nutr; 1994 Feb; 71(2):203-7. PubMed ID: 8142332
[TBL] [Abstract][Full Text] [Related]
15. Dependence of intestinal iron absorption on the valency state of iron.
Wollenberg P; Rummel W
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):578-82. PubMed ID: 3125486
[TBL] [Abstract][Full Text] [Related]
16. Iron dissociates from the NaFeEDTA complex prior to or during intestinal absorption in rats.
Zhu L; Yeung CK; Glahn RP; Miller DD
J Agric Food Chem; 2006 Oct; 54(20):7929-34. PubMed ID: 17002472
[TBL] [Abstract][Full Text] [Related]
17. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
Gasche C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Büning C; Howaldt S; Stallmach A;
Inflamm Bowel Dis; 2015 Mar; 21(3):579-88. PubMed ID: 25545376
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of 59Fe movement across the intestinal wall in duodenal rat segments ex vivo.
Schümann K; Elsenhans B; Forth W
Am J Physiol; 1999 Feb; 276(2):G431-40. PubMed ID: 9950817
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of iron and cyanide from 59Fe- and 14C-labelled hexacyanoferrates(II) in rats.
Nielsen P; Dresow B; Fischer R; Heinrich HC
Z Naturforsch C J Biosci; 1990 Jun; 45(6):681-90. PubMed ID: 2400471
[TBL] [Abstract][Full Text] [Related]
20. Chelators affecting iron absorption in mice.
Kontoghiorghes GJ
Arzneimittelforschung; 1990 Dec; 40(12):1332-5. PubMed ID: 2095129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
